Understanding the enigma of a novel pediatric disease, multisystem inflammatory syndrome in children: when COVID-19 throws a curveball at children's health
DOI:
https://doi.org/10.18203/2349-3933.ijam20231459Keywords:
MIS-C, COVID-19, Pediatric inflammatory multisystem syndrome, SARS-CoV-2 infectionAbstract
Multisystem inflammatory syndrome in children (MIS-C) is a rare and potentially life-threatening condition that has emerged as a post-infectious complication of COVID-19. MIS-C is characterized by widespread inflammation affecting multiple organ systems, including the heart, lungs, kidneys, and gastrointestinal tract. The condition primarily affects school-aged children and adolescents, with most cases occurring several weeks after a COVID-19 infection. The exact pathophysiology of MIS-C is not yet fully understood, but it is thought to result from an abnormal immune response triggered by the SARS-CoV-2 virus. The clinical presentation of MIS-C is highly variable, and patients may present with fever, rash, conjunctivitis, abdominal pain, vomiting, diarrhea, and cardiac dysfunction. Early recognition and diagnosis of MIS-C are crucial for the prompt initiation of treatment, which typically involves immunomodulatory therapy and supportive care. The diagnosis of MIS-C is based on a combination of clinical and laboratory findings, including elevated inflammatory markers, cardiac biomarkers, and evidence of recent SARS-CoV-2 infection. The management of MIS-C is challenging, and treatment strategies continue to evolve as our understanding of the condition improves. Ongoing research is focused on optimizing diagnostic and therapeutic approaches to improve outcomes for affected children. This review article provides an overview of the current state of knowledge regarding MIS-C, including its epidemiology, clinical presentation, diagnostic evaluation, and management strategies.
References
MIS-C and COVID-19: Uncommon but serious inflammatory syndrome in kids and teens. Available at: https://www.hopkinsmedicine.org/health/ conditions-and- diseases/coronavirus/misc-and-covid19-rare-inflammatory-syndrome-in-kids-and- teens. Accessed on 22 August 2023.
Pediatric COVID-19 international collaborative. WFPICCS - Pediatric Intensive & Critical Care website. Available at: https://wfpiccs.org /education/pediatric-covid-19-international-collaborative/. Accessed on 22 January 2023.
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-7.
Centre for Disease Control and Prevention. Multisystem Inflammatory Syndrome (MIS). Available at: https://www.cdc.gov/mis/index.html. Accessed on 22 January 2023.
Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int J Environ Res Public Health. 2021;18(5):2621.
Rowley AH. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat Rev Immunol. 2020;20(8):453-4.
Carter MJ, Fish M, Jennings A, Doores KJ, Wellman P, Seow J, et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat Med. 2020;26(11):1701-7.
Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, Gupta A. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev. 2021;38:51-7.
Nikolopoulou GB, Maltezou HC. COVID-19 in Children: Where do we Stand? Arch Med Res. 2022;53(1):1-8.
Abdulamir A, Hafidh R. The possible immunological pathways for the variable immunopathogenesis of COVID-19 infections among healthy adults, elderly and children. Electron J Gen Med. 2020;17:em202.2020.
Shekerdemian LS, Mahmood NR, Wolfe KK. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174:868-73.
Abrams JY, Godfred-Cato SE, Oster ME, Chow EJ, Koumans EH, Bryant B, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systemic review. J Pediatr. 2020;226:45-54.
Maltezou HC, Pavli A, Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021;9(5):497.
Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome. Available at: https://www.cdc.gov/mis/index.html. Accessed on 22 January 2023.
Brouard J, Varricchio F, Vabret A. Multisystem Inflammatory Syndrome in Neonates: A Systematic Review. Pediatr Infect Dis J. 2021;40(6):e218-22.
Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Outbreak of Kawasaki disease in children during COVID-19 pandemic: a prospective observational study in Paris, France. Lancet Child Adolesc Health. 2020;4(11):e767-74.
World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. Available at: https://www.who.int/ publications/i/item/multisystem-inflammatory-syndrome-in- children-and-adolescents-with-covid-19. Accessed on 22 January 2023.
Elsevier. Multisystem inflammatory syndrome in children (MIS-C). Available at: https://www. elsevier.com/ data/assets/pdf_file/0007/1029418/ Multisystem- inflammatory-syndrome-in-children. pdf. Accessed on 22 January 2023.
Weisberg SP, Connors T, Zhu Y, Baldwin M, Lin WH, Wontakal S, et al. Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19. medRxiv. 2020;07.12.20151068.
Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D, et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohisto-chemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020;183(4):729-37.
Diorio C, Henrickson SE, Vella LA, McNerney KO, Chase J, Burudpakdee C, et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest. 2020;130(11):5967-75.
Schwartz M. MIS-C: post-infectious syndrome or persistent infection? Lancet Infect Dis. 2021;21(5):e116.
Bouslama B, Pierret C, Khelfaoui F, Bellanné-Chantelot C, Donadieu J, Héritier S. Post-COVID-19 severe neutropenia. Pediatr Blood Cancer. 2021;68(5):e28866.
Anderson JE, Campbell JA, Durowoju L, Greenberg SLM, Rice-Townsend SE, Gow KW, Avansino J. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) presenting as appendicitis with shock. J Pediatr Surg Case Rep. 2021;71:101913.
Kashyap H, Gupta V, Gupta A, Gupta T, Sharma S, Valjiyani S. Post-COVID Syndrome (MIS-C) with Refractory Status Epilepticus. Indian J Pediatr. 2021;88(7):721.
Vella LA, Rowley AH. Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children. Curr Pediatr Rep. 2021;9(4):83-92.
Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J, et al. COVID-19–associated multisystem inflammatory syndrome in children—United States, March–July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1074-80.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259-69.
Ceballos-Liceaga SE, Villarreal-Velarde H. Pediatric multisystem inflammatory syndrome associated with COVID-19 in a developing country: A case report. IDCases. 2021;25:e01293.
Farias ECF, Justino MCA, Mello MLFMF. Multisystem inflammatory syndrome in a child associated with coronavirus disease 19 in the Brazilian amazon: fatal outcome in an infant. Rev Paul Pediatr. 2020;38:e2020165.
Baggio S, L'Huillier AG, Yerly S, Bellon G, Wagner N, Rohr M, et al. SARS-CoV-2-related pediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Eurosurveillance. 2021;26(10):2001010.
Ouldali N, Pouletty M, Mariani P, Beyler C, Blachier A, Bonacorsi S, et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Health. 2020;4(9):662-8.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135(17):e927-99.
Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J, et al. COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1074-80.
Carter MJ, Fish M, Jennings A, Doores KJ, Wellman P, Seow J, et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nature Med. 2020;26(11):1701-7.
Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). Available at: https://www.cdc.gov/ mis-c/index.html. Accessed on 22 January 2023.
Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009;9(5):281-90.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135(17):e927-99.
HAN archive - 00432 - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). Available at: https://emergency.cdc.gov/han/2020/han00432. asp?deliveryName=USCDC_511- DM28431. Accessed on 22 January 2023.
Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020;383(4):334-46.
Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, et al. Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series. J Pediatric Infect Dis Soc. 2020;9(3):393-8.
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2. Arthritis Rheumatol. 2021;73(4):e13-29.
Carter MJ, Shankar-Hari M, Tibby SM. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease. Lancet. 2020;395(10240):e73-4.
Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. 2020;183(4):968-81.
Diorio C, Henrickson SE, Vella LA, McNerney KO, Chase J, Burudpakdee C, et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest. 2020;130(11):5967-75.
Gruber CN, Patel RS, Trachtman R, Lepow L, Amanat F, Krammer F, et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome. J Clin Invest. 2020;130(12):6634-47.
Lee PY, Day-Lewis M, Henderson LA, Friedman KG, Lo J, Roberts JE, et al. Distinct Clinical and Immunological Features of SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in Children. J Clin Invest. 2020;130(11):594.
